首页 文献索引 SCI期刊 AI助手
期刊目录筛选

期刊名:Drug metabolism and pharmacokinetics

缩写:DRUG METAB PHARMACOK

ISSN:1347-4367

e-ISSN:1880-0920

IF/分区:2.2/Q3

文章目录 更多期刊信息

共收录本刊相关文章索引1120
Clinical Trial Case Reports Meta-Analysis RCT Review Systematic Review
Classical Article Case Reports Clinical Study Clinical Trial Clinical Trial Protocol Comment Comparative Study Editorial Guideline Letter Meta-Analysis Multicenter Study Observational Study Randomized Controlled Trial Review Systematic Review
Koichi Handa,Hideaki Mamada,Shinji Nakayama et al. Koichi Handa et al.
Advances in machine learning and artificial intelligence have recently extended to the quantitative prediction of drug-drug interaction (DDI). Because DDIs arise from diverse mechanisms and the required level of predictive accuracy varies w...
Lloyd Wei Tat Tang Lloyd Wei Tat Tang
Hydralazine is commonly employed as a time-dependent inhibitor of aldehyde oxidase (AO) in human hepatocytes for reaction phenotyping yet profound inter-lot variability in its inhibitory effects has been reported. To date, the exact mechani...
Kazuya Maeda Kazuya Maeda
In the drug development process, quantitative prediction of drug-drug interaction (DDI) risk must be a vital evaluation item to ensure drug safety in real clinical settings. Therefore, according to the ICH M12 regulatory guideline, it is st...
Takuto Inamoto,Masataka Nakano,Tatsuki Fukami et al. Takuto Inamoto et al.
Methylation of adenosine at the N6 position (m6A modification) is the most prevalent epitranscriptomic modification in mammals, regulating RNA stability, splicing, translation, and decay. Growing evidence has revealed that m6A modification ...
Miyu Nakayama,Sho Sato,Syunsuke Yamamoto Miyu Nakayama
In gene therapy involving the use of adeno-associated virus (AAV) vectors, the biodistribution of vector genome has been expressed in units of "copies/μg genomic DNA (gDNA)." However, gDNA content vary across tissues, thus affecting the bi...
Xinning Yang,Carolien Versantvoort,Motohiro Hoshino et al. Xinning Yang et al.
Drug-drug interaction (DDI) is an important factor to consider when determining the drug and optimal dose for individual patients. The DDI potential of an investigational drug is routinely evaluated during development. For pharmacokinetics-...
Taiji Miyake,Haruka Tsutsui Taiji Miyake
Humanized liver chimeric mice, including hu-PXB, hu-FRG, and hu-TK-NOG mice, have emerged as valuable tools for predicting human pharmacokinetics in drug discovery and development. These models, featuring human hepatocytes transplanted into...
Krisztina Herédi-Szabó,Sumito Ito,Xiaomin Liang et al. Krisztina Herédi-Szabó et al.
Drug transporters play essential roles in governing the absorption, distribution, metabolism, and excretion (ADME) of therapeutic drugs. Transporter modulation frequently contributes to clinically significant drug-drug interactions (DDIs). ...
David M Stresser,Michael A Zientek David M Stresser
Uridine 5'-diphospho-glucuronosyltransferases (UGT) are the best known and most well characterized sugar conjugation biotransformation enzymes. Their main function is to catalyze conjugation of glucuronic acid (sugar) to an exposed (or crea...